scholarly journals Postmortem Demonstration of the Source of Pulmonary Thromboembolism: The Importance of the Autopsy

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Gina Elhammady ◽  
Andrew T. Schubeck ◽  
Vicky El-Najjar ◽  
Morton J. Robinson
Keyword(s):  
Pulmonary Embolism ◽  
Pulmonary Thromboembolism ◽  
Postmortem Examination ◽  
Pelvic Vein ◽  
Vein Thrombosis ◽  
Potential Source ◽  
Venous Thromboses

Periprostatic or paravaginal venous thromboses are rarely considered clinically as sites of clot origin in patients with pulmonary thromboembolism. The majority of emboli have been demonstrated to originate in the veins of the legs. This report raises awareness of pelvic vein thrombosis as a potential source of pulmonary embolism that is rarely considered or detected clinically, and which usually requires postmortem examination for recognition. It also reviews the possible routes emboli may take to reach the lungs.

Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: A case report

1984 ◽  
Vol 149 (7) ◽  
pp. 796-798 ◽  
Author(s):  
Daniel L. Clarke-Pearson ◽  
R.Edward Coleman ◽  
Neil Petry ◽  
Ingrid S. Synan ◽  
William T. Creasman
Keyword(s):  
Pulmonary Embolism ◽  
Case Report ◽  
Pelvic Vein ◽  
Vein Thrombosis ◽  
Indium 111

Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: A prospective study

1992 ◽  
Vol 16 (5) ◽  
pp. 0715-0722 ◽  
Author(s):  
H. Brownell Wheeler ◽  
Hugo Brownell Partsch ◽  
Karin Brownell Oburger ◽  
Adolf Brownell Mostbeck ◽  
Beatrix Brownell K[ouml ]nig
Keyword(s):  
Pulmonary Embolism ◽  
Prospective Study ◽  
Pelvic Vein ◽  
Vein Thrombosis ◽  
A Prospective Study

scholarly journals Acute Pulmonary Embolism Post COVID-19 Pneumonia – A Case Report

2021 ◽  
pp. 315-318
Author(s):  
M. Nitharsha Prakash ◽  
N. N. Anand ◽  
Karthick Ramalingam ◽  
G. Venkat Sai
Keyword(s):  
Pulmonary Embolism ◽  
Acute Pulmonary Embolism ◽  
Pulmonary Thromboembolism ◽  
Evidence Based ◽  
Post Discharge ◽  
Vte Prophylaxis ◽  
Vein Thrombosis ◽  
Coagulation Therapy ◽  
Thromboembolism Events ◽  
Deep Vein

COVID-19 has been associated with multiple venous thromboembolism events such as pulmonary embolism and deep vein thrombosis. Here we report a 64-year male with COVID-19 pneumonia who developed pulmonary thromboembolism following the COVID illness. This patient developed VTE complication in spite of receiving anti-coagulation therapy during admission. This case brings out the need for evidence-based post-discharge VTE prophylaxis approach and guidelines in patients who recover from COVID-19.

scholarly journals Proximal extent of pelvic vein thrombosis and its association with pulmonary embolism

2003 ◽  
Vol 37 (3) ◽  
pp. 518-522 ◽  
Author(s):  
Barbara Borst-Krafek ◽  
Astrid Maria Fink ◽  
Claudia Lipp ◽  
Helmut Umek ◽  
Horst Köhn ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Pelvic Vein ◽  
Vein Thrombosis

scholarly journals Sub-Massive Pulmonary Thromboembolism with Out Deep Vein Thrombosis

2016 ◽  
Vol 01 (04) ◽  
pp. 032-035
Author(s):  
Seetharam Vankudoth ◽  
Madhurima banoth
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Protein C ◽  
Causes Of Death ◽  
Pulmonary Thromboembolism ◽  
Target Range ◽  
Systemic Thrombolysis ◽  
Vein Thrombosis ◽  
Deep Vein

AbstractVenous thromboembolism, causing Pulmonary Embolism (PE), is one of the major cardiovascular causes of death. We are reporting three cases of pulmonary thromboembolism without deep vein thrombosis and with normal levels of homocysteine, protein C and S, anti-thrombin III levels. All three cases managed with thrombolysis with streptokinase, out of three cases two cases systemic thrombolysis given and one case catheter guided thrombolysis given and discharged on oral anticoagulant with target range of PT with INR 2-3.on subsequent follow-up one case was diagnosed lymphoma and he was treated successfully in our institution.

scholarly journals Prevalence of Pelvic Vein Pathology in Patients with Cryptogenic Stroke and Patent Foramen Ovale Undergoing MRV Pelvis

2015 ◽  
Vol 39 (3-4) ◽  
pp. 216-223 ◽  
Author(s):  
Marcey Osgood ◽  
Elizabeth Budman ◽  
Raphael Carandang ◽  
Richard P. Goddeau, Jr. ◽  
Nils Henninger
Keyword(s):  
Risk Factors ◽  
Logistic Regression ◽  
Patent Foramen Ovale ◽  
Cryptogenic Stroke ◽  
Foramen Ovale ◽  
Pelvic Vein ◽  
Vein Thrombosis ◽  
Potential Source ◽  
Vein Imaging ◽  
Paradoxical Emboli

Background: A substantial proportion of ischemic strokes has no any identified underlying cause. Notably, the prevalence of a patent foramen ovale (PFO) is increased in cryptogenic stroke (CS) populations, which may serve as a conduit for paradoxical emboli originating from deep vein thrombosis (DVT) including the pelvic veins. Yet, there are no published guidelines for the assessment of pelvic veins as part of the stroke workup and few studies have systematically investigated pelvic veins as a potential source for paradoxical emboli in CS patients. Further, there is a relative paucity of data regarding pelvic DVT in CS and results have been conflicting. Hence, we sought to determine the prevalence of pelvic DVT in select CS patients with PFO who underwent magnetic resonance venography (MRV). Methods: We retrospectively identified patients (n = 50) who underwent contrast-enhanced pelvic MRV at the discretion of the treating physician for the evaluation of CS in the presence of a PFO during hospitalization at a single academic stroke center between January 2011 through December 2013. Multivariable logistic regression analyses were used to assess for factors independently associated with the presence of an abnormal MRV pelvis. Results: Patients (47 ± 13 years of age) had MRV performed 4 ± 3 days after their incident stroke. Nine patients had an abnormal MRV (18%). Of these, four (8%) had pelvic vein thrombosis and 5 (10%) a May-Thurner anatomic variant. All patients with pelvic DVT were subsequently anticoagulated with warfarin (none had abnormal hypercoagulability testing). Clinical clues suggesting paradoxical embolism were present in as many as 40% of patients. On multivariable logistic regression, a history of any risk factors predisposing to DVT (OR 6.7; coefficient 1.9; BCa 95% CI 0.08-20.2; p = 0.014) as well as the number of predisposing risk factors (OR 3.9; coefficient 1.4; BCa 95% CI 0.25-4.2; p = 0.005) predicted the presence of pelvic vein pathology on MRV. Conclusion: We demonstrate a relatively high prevalence of pelvic DVT among select CS patients emphasizing the importance of considering the pelvic veins as a potential source for emboli particularly in the presence of risk factors known to predispose DVT. Because patients were included at the treating physician's discretion, our results reflect ‘real-life' practice. Our results may be of clinical importance as inclusion of pelvic vein imaging in CS patients with PFO had impactful therapeutic and nosologic implications. Further study is needed to define patients most likely to benefit from pelvic vein imaging.

scholarly journals Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: A prospective study

1992 ◽  
Vol 16 (5) ◽  
pp. 715-722 ◽  
Author(s):  
Hugo Partsch ◽  
Karin Oburger ◽  
Adolf Mostbeck ◽  
Beatrix König ◽  
Horst Köhn
Keyword(s):  
Pulmonary Embolism ◽  
Prospective Study ◽  
Pelvic Vein ◽  
Vein Thrombosis ◽  
A Prospective Study

scholarly journals Case of recurrent pulmonary thromboembolism due to therapeutic non-compliance

2021 ◽  
pp. 223
Author(s):  
Keyword(s):  
Pulmonary Embolism ◽  
Venous Thromboembolism ◽  
Pulmonary Thromboembolism ◽  
Anticoagulation Therapy ◽  
Vena Cava ◽  
Complete Recovery ◽  
Underlying Disease ◽  
Jugular Veins ◽  
Vein Thrombosis ◽  
Appropriate Treatment

Pulmonary embolism occurs when thrombi enter the pulmonary arterial circulation. Most pulmonary embolisms are the result of deep venous thrombosis of the pelvic limbs, chest or pelvis, and, less commonly, the jugular veins or inferior vena cava. Venous thromboembolism includes deep vein thrombosis and pulmonary embolism. It is the third most common cardiovascular disease, with a total annual incidence of 100-200 per 100 000 population. INTRODUCTION: Acute pulmonary embolism is the most serious clinical presentation of venous thromboembolism. Overall, pulmonary embolism is a major cause of mortality, morbidity and hospitalization. Mortality in pulmonary embolism depends on haemodynamic impairment, age and co morbidities. The prognosis of patients with pulmonary embolism depends on two factors : underlying disease state plus diagnosis, and appropriate treatment. Approximately 10% of patients who develop pulmonary embolism die within the first hour, and 30% subsequently die of recurrent embolism. CASE PRESENTATION: In this presentation we present the case of a 49-year-old male patient without co morbidities, presented repeatedly to the Emergency Room for symptoms suggestive of pulmonary thromboembolism, who benefited from life-saving therapies due to timely diagnosis and appropriate treatment, with subsequent favorable outcome. CONCLUSIONS: The particularity of the case is that, on the one hand, the thromboembolic event recurred in a short time, on the other hand, the evolution was favorable in both cases, with complete recovery of right ventricular function and disappearance of pulmonary hypertension, despite the fact that the patient was non-compliant with initial anticoagulation therapy. This was due to both early diagnosis and timely administration of appropriate treatment.

scholarly journals Proteus Syndrome: A Rare Case in An Adult Ward

2021 ◽  
Author(s):  
Catarina Duarte Santos ◽  
Rita Lizardo Grácio ◽  
Tatiana Costa Pires ◽  
Miguel González Santos ◽  
Rita Jesus Rodrigues ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Rare Case ◽  
Pulmonary Thromboembolism ◽  
Vascular Malformations ◽  
Proteus Syndrome ◽  
Left Hemithorax ◽  
Live Births ◽  
Vein Thrombosis ◽  
Deep Vein

Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern. It has an estimated prevalence of less than 1/1,000,000 live births. The diagnosis can be difficult because the phenotypes of the patients are variable. Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations). Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism. The authors present the case of a patient with Proteus syndrome who was admitted because of pulmonary thromboembolism and presented hypertrophy of the left arm and left hemithorax.

Sign in / Sign up

Export Citation Format

Share Document